SCIENCEPLUSPLEASE LLC

Medtech

Noninvasive scalp-mounted device for detecting cortical spreading depolarization in acute brain injury using proprietary DC-capable electrodes, bio-signal amplifiers, and a digital detection algorithm

Grants
$1.5M
4 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Noninvasive scalp detection of cortical spreading depression for brain injury$349,466
Federal grantDepartment of Health and Human Services · Phase I · Non-invasive scalp detection of cortical spreading depression for brain injury$742,826
Federal grantDepartment of Health and Human Services · Phase I · Noninvasive scalp detection of cortical spreading depression for brain injury$343,360
Federal grantDepartment of Health and Human Services · Phase I · Non-invasive scalp detection of cortical spreading depression for brain injury$50,000
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1538IntuScope, Inc.—$1.0M
1539Radiatric, Inc.—$400K
1540MEDICARBONE, INC.——
1541SCIENCEPLUSPLEASE LLC——
1542Enhanced Ultrasound Inc—$190K
1543QUA, INC.—$530K
1544Plasmonic Diagnostics LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.